| Restatement To Previously Issued Condensed Consolidated Financial Statements |
The impact of this change as of and
for the year ended December 31, 2016, is as follows (in thousands, except share and per share data):
| |
|
Year ended December 31, 2016 |
|
| |
|
As Previously Reported |
|
|
Restatement - Warrant Liability |
|
|
As Restated After Restatement |
|
| Total other expense, net |
|
$ |
(5,063 |
) |
|
$ |
1,835 |
|
|
$ |
(3,228 |
) |
| Total net loss/comprehensive loss |
|
|
(16,598 |
) |
|
|
1,835 |
|
|
|
(14,763 |
) |
| Deemed dividend related to beneficial conversion feature and accretion of a discount a Series A Preferred Stock |
|
|
(6,278 |
) |
|
|
- |
|
|
|
(6,278 |
) |
| Net loss attributable to common stockholders |
|
$ |
(22,876 |
) |
|
$ |
1,835 |
|
|
$ |
(21,041 |
) |
| Net loss per share attributable to common stockholders: |
|
|
|
|
|
|
|
|
|
|
|
|
| Basic and diluted |
|
$ |
(14.82 |
) |
|
$ |
1.19 |
|
|
$ |
(13.63 |
) |
| Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted
|
|
|
1,543,735 |
|
|
|
- |
|
|
|
1,543,735 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, $0.01 par value |
|
$ |
22 |
|
|
|
|
|
|
$ |
22 |
|
| Additional paid-in capital |
|
|
227,486 |
|
|
|
(4,973 |
) |
|
|
222,513 |
|
| Accumulated deficit |
|
|
(213,135 |
) |
|
|
1,835 |
|
|
|
(211,300 |
) |
| Total stockholders' equity |
|
$ |
14,373 |
|
|
$ |
(3,138 |
) |
|
$ |
11,235 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative liabilities, current portion |
|
$ |
- |
|
|
$ |
3,137 |
|
|
$ |
3,137 |
|
|